{
  "report_rows": [
    {
      "kpi": "Operating EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.06 vs. cons $2.07",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$6.44B vs. cons $6.433B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total comparable-sales growth",
      "prediction": "MISS",
      "answer": "pred ~2.8% vs. cons 2.9%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$7.50-$8.00 vs. cons $7.73",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 total sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.0%-5.5% vs. cons FY sales $25.46B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3/Q4 margin and Iran-cost commentary",
      "prediction": "UNKNOWN",
      "answer": "guide: Q2 cost trough / H2 improvement; no reliable numerical consensus",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 in-line results and maintained FY guidance leave H2 estimates vulnerable",
  "day5_confidence": "LOW"
}